Correlation Between Johnson Johnson and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and X4 Pharmaceuticals, you can compare the effects of market volatilities on Johnson Johnson and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and X4 Pharmaceuticals.
Diversification Opportunities for Johnson Johnson and X4 Pharmaceuticals
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Johnson and XFOR is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Johnson Johnson and X4 Pharmaceuticals
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.12 times more return on investment than X4 Pharmaceuticals. However, Johnson Johnson is 8.43 times less risky than X4 Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 14,220 in Johnson Johnson on December 28, 2024 and sell it today you would earn a total of 2,093 from holding Johnson Johnson or generate 14.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. X4 Pharmaceuticals
Performance |
Timeline |
Johnson Johnson |
X4 Pharmaceuticals |
Johnson Johnson and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and X4 Pharmaceuticals
The main advantage of trading using opposite Johnson Johnson and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |